AWM
DNA icon

Axxcess Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Axxcess Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,316
Closed -$17.6K – 903
2024
Q2 		$17.6K Sell
1,316
-3,649
-73% -$109K ﹤0.01% 839
2024
Q1 		$230K Buy
4,965
+1,295
+35% +$67K 0.01% 760
2023
Q4 		$248K Sell
3,670
-350
-9% -$21.4K 0.01% 713
2023
Q3 		$291K Buy
4,020
+1,572
+64% +$126K 0.01% 605
2023
Q2 		$182K Buy
2,448
+505
+26% +$29.9K 0.01% 559
2023
Q1 		$103K Buy
1,943
+632
+48% +$40K 0.01% 616
2022
Q4 		$88.6K Sell
1,311
-336
-20% -$30.9K 0.01% 596
2022
Q3 		$206K Sell
1,647
-113
-6% -$13.5K 0.02% 495
2022
Q2 		$168K Buy
1,760
+671
+62% +$81.8K 0.02% 503
2022
Q1 		$176K Buy
+1,089
New +$212K 0.01% 597

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return